155 related articles for article (PubMed ID: 11590897)
21. Urea kinetic analysis of automated peritoneal dialysis allows calculation of a CAPD-equivalent Kt/V(urea).
Schurman SJ; Shoemaker LR; Warady BA
Kidney Int; 2000 Sep; 58(3):1318-24. PubMed ID: 10972696
[TBL] [Abstract][Full Text] [Related]
22. Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study.
Santos EJF; Hortegal EV; Serra HO; Lages JS; Salgado-Filho N; Dos Santos AM
Braz J Med Biol Res; 2018; 51(7):e7288. PubMed ID: 29742267
[TBL] [Abstract][Full Text] [Related]
23. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20.
Kalantar-Zadeh K; Supasyndh O; Lehn RS; McAllister CJ; Kopple JD
J Ren Nutr; 2003 Jan; 13(1):15-25. PubMed ID: 12563619
[TBL] [Abstract][Full Text] [Related]
24. High Erythropoiesis Resistance Index Is a Significant Predictor of Cardiovascular and All-Cause Mortality in Chinese Maintenance Hemodialysis Patients.
Lu X; Zhang J; Wang S; Yu Q; Li H
Mediators Inflamm; 2020; 2020():1027230. PubMed ID: 33293895
[TBL] [Abstract][Full Text] [Related]
25. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients.
Petrulienė K; Žiginskienė E; Kuzminskis V; Nedzelskienė I; Bumblytė IA
Medicina (Kaunas); 2017; 53(2):90-100. PubMed ID: 28416170
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
[TBL] [Abstract][Full Text] [Related]
27. Predictors of serum creatinine in haemodialysis patients: a cross-sectional analysis.
Vernaglione L; Marangi AL; Cristofano C; Giordano R; Chimienti S; Basile C
Nephrol Dial Transplant; 2003 Jun; 18(6):1209-13. PubMed ID: 12748357
[TBL] [Abstract][Full Text] [Related]
28. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme gene polymorphism and erythropoietin requirement.
Varagunam M; McCloskey DJ; Sinnott PJ; Raftery MJ; Yaqoob MM
Perit Dial Int; 2003; 23(2):111-5. PubMed ID: 12713075
[TBL] [Abstract][Full Text] [Related]
30. The relation between nutrition indices and age in patients on continuous ambulatory peritoneal dialysis receiving similar small solute clearances.
Tzamaloukas AH; Oreopoulos DG; Murata GH; Servilla K; Rao P; Din S; Malhotra D
Int Urol Nephrol; 2001; 32(3):449-58. PubMed ID: 11583370
[TBL] [Abstract][Full Text] [Related]
31. Serum cystatin C for estimation of residual renal function in children on peritoneal dialysis.
Kim SJ; Sohn YB; Park SW; Jin DK; Paik KH
Pediatr Nephrol; 2011 Mar; 26(3):433-40. PubMed ID: 21069389
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
[TBL] [Abstract][Full Text] [Related]
33. Factors Related to Erythropoietin Hyporesponsiveness in Peritoneal Dialysis Patients with Anemia.
Makruasi N; Changsirikulchai S; Janma J; Rattanamongkolgul S
J Med Assoc Thai; 2016 Nov; 99 Suppl 8():S48-S52. PubMed ID: 29901907
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of C-reactive protein in patients on hemodialysis: a longitudinal study.
Teruel JL; Marcen R; Ocaña J; Fernández-Lucas M; Rivera M; Tabernero G; Ortuño J
Nephron Clin Pract; 2005; 100(4):c140-5. PubMed ID: 15855797
[TBL] [Abstract][Full Text] [Related]
35. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
36. Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study.
Ogawa T; Shimizu H; Kyono A; Sato M; Yamashita T; Otsuka K; Nitta K
Int Urol Nephrol; 2014 Jan; 46(1):151-9. PubMed ID: 23807369
[TBL] [Abstract][Full Text] [Related]
37. [Gastroesophageal reflux disease and its' influence on nutritional status in patients treated with peritoneal dialysis].
Stojakowska M; Błaut U; Smoleńiski O; Thor PJ
Folia Med Cracov; 2005; 46(3-4):59-66. PubMed ID: 17252988
[TBL] [Abstract][Full Text] [Related]
38. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
Navarro JF; Mora C; Macía M; García J
Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
[TBL] [Abstract][Full Text] [Related]
39. Importance of dialysis adequacy in mortality and morbidity of chinese CAPD patients.
Szeto CC; Wong TY; Leung CB; Wang AY; Law MC; Lui SF; Li PK
Kidney Int; 2000 Jul; 58(1):400-7. PubMed ID: 10886588
[TBL] [Abstract][Full Text] [Related]
40. Increase of the bioavailability of intraperitoneal erythropoietin in children on peritoneal dialysis by administration in small dialysis bags.
Reddingius RE; de Boer AW; Schröder CH; Willems JL; Monnens LA
Perit Dial Int; 1997; 17(5):467-70. PubMed ID: 9358528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
